Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated ...

Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults.

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

In a new cross-sectional analysis of 6,746 hospitalized adults aged 60 and older in 20 states, increased respiratory ...

More than 170,000 people still sought medical help for acute respiratory infection (ARI), including 22,000 with ...